Topics
late
AI
Amazon
Image Credits:David Paul Morris/Bloomberg / Getty Images
Apps
Biotech & Health
Climate
Image Credits:David Paul Morris/Bloomberg / Getty Images
Cloud Computing
Commerce
Crypto
Enterprise
EVs
Fintech
Fundraising
Gadgets
stake
Government & Policy
Hardware
Layoffs
Media & Entertainment
Meta
Microsoft
privateness
Robotics
surety
societal
outer space
Startups
TikTok
Transportation
Venture
More from TechCrunch
Events
Startup Battlefield
StrictlyVC
newssheet
Podcasts
Videos
Partner Content
TechCrunch Brand Studio
Crunchboard
Contact Us
LinkedIn laminitis Reid Hoffman and Siddhartha Mukherjee , cancer researcher and generator of the book “ The Emperor of All Maladies , ” have co - base an AI - powered drug discovery inauguration , Manas AI . The company , which will initially centre on white meat cancer , prostate malignant neoplastic disease , and lymphoma , has raised $ 24.6 million in seed support from Hoffman , General Catalyst , and Greylock .
Manas AI ’s Washington haul pales equate with some other startups trying to use AI models to rise novel drug . Last year , Xaira , which claim that it was quick to start developing drug , launch with amassive $ 1 billionin initial funding . Treeline Biosciences is another company that uses AI for drug discovery and raised $ 422 million last twelvemonth , Endpts reported .
Manas AI claims it will design molecule with AI , then test them in a squiffy science lab , Hoffman reportedly saidduring the presentation of his fresh leger “ Superagency . ” The outfit alsosaysit will utilise Microsoft ’s cloud computing platform , Azure , and Microsoft ’s “ deep domain noesis in AI ” to develop refreshing medicines .
Hoffman has close ties to Microsoft , which splendidly acquire his earlier company , LinkedIn , in ablockbuster dealin 2016 .
